[DPHARMA] QoQ Annualized Quarter Result on 31-Mar-2010 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
25-May-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
31-Mar-2010 [#1]
Profit Trend
QoQ- -32.13%
YoY- -26.48%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
Revenue 131,437 132,322 129,554 115,184 123,766 125,221 123,456 4.25%
PBT 35,408 35,736 33,164 27,168 38,215 39,473 40,674 -8.80%
Tax -6,739 -8,996 -8,292 -6,648 -7,982 -9,621 -9,754 -21.79%
NP 28,669 26,740 24,872 20,520 30,233 29,852 30,920 -4.90%
-
NP to SH 28,669 26,740 24,872 20,520 30,233 29,852 30,920 -4.90%
-
Tax Rate 19.03% 25.17% 25.00% 24.47% 20.89% 24.37% 23.98% -
Total Cost 102,768 105,582 104,682 94,664 93,533 95,369 92,536 7.22%
-
Net Worth 156,881 148,504 140,182 146,967 142,975 142,967 136,003 9.96%
Dividend
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
Div 222 - 12,491 - 24,985 111 166 21.32%
Div Payout % 0.77% - 50.22% - 82.64% 0.37% 0.54% -
Equity
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
Net Worth 156,881 148,504 140,182 146,967 142,975 142,967 136,003 9.96%
NOSH 138,832 138,788 138,794 138,648 138,810 138,803 138,779 0.02%
Ratio Analysis
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
NP Margin 21.81% 20.21% 19.20% 17.81% 24.43% 23.84% 25.05% -
ROE 18.27% 18.01% 17.74% 13.96% 21.15% 20.88% 22.73% -
Per Share
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
RPS 94.67 95.34 93.34 83.08 89.16 90.21 88.96 4.22%
EPS 20.65 19.27 17.92 14.80 21.78 21.51 22.28 -4.92%
DPS 0.16 0.00 9.00 0.00 18.00 0.08 0.12 21.07%
NAPS 1.13 1.07 1.01 1.06 1.03 1.03 0.98 9.93%
Adjusted Per Share Value based on latest NOSH - 138,648
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
RPS 13.65 13.75 13.46 11.97 12.86 13.01 12.82 4.25%
EPS 2.98 2.78 2.58 2.13 3.14 3.10 3.21 -4.82%
DPS 0.02 0.00 1.30 0.00 2.60 0.01 0.02 0.00%
NAPS 0.163 0.1543 0.1456 0.1527 0.1485 0.1485 0.1413 9.96%
Price Multiplier on Financial Quarter End Date
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
Date 30/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 -
Price 2.39 2.44 2.45 2.40 2.40 2.58 2.13 -
P/RPS 2.52 2.56 2.62 2.89 2.69 2.86 2.39 3.58%
P/EPS 11.57 12.66 13.67 16.22 11.02 12.00 9.56 13.52%
EY 8.64 7.90 7.31 6.17 9.08 8.34 10.46 -11.93%
DY 0.07 0.00 3.67 0.00 7.50 0.03 0.06 10.79%
P/NAPS 2.12 2.28 2.43 2.26 2.33 2.50 2.17 -1.53%
Price Multiplier on Announcement Date
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
Date 23/02/11 26/11/10 24/08/10 25/05/10 23/02/10 20/11/09 26/08/09 -
Price 2.45 2.38 2.45 2.38 2.33 2.49 2.50 -
P/RPS 2.59 2.50 2.62 2.86 2.61 2.76 2.81 -5.27%
P/EPS 11.86 12.35 13.67 16.08 10.70 11.58 11.22 3.75%
EY 8.43 8.10 7.31 6.22 9.35 8.64 8.91 -3.61%
DY 0.07 0.00 3.67 0.00 7.73 0.03 0.05 25.06%
P/NAPS 2.17 2.22 2.43 2.25 2.26 2.42 2.55 -10.17%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment